Loflucarban | CAS#790-69-2 | antiinfective drug

MedKoo Cat#: 599154 | Name: Loflucarban

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Loflucarban is an antiinfective drug.

Chemical Structure

Loflucarban

CAS#790-69-2

Theoretical Analysis

MedKoo Cat#: 599154

Name: Loflucarban

CAS#: 790-69-2

Chemical Formula: C13H9Cl2FN2S

Exact Mass: 313.9848

Molecular Weight: 315.18

Elemental Analysis: C, 49.54; H, 2.88; Cl, 22.49; F, 6.03; N, 8.89; S, 10.17

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Loflucarban; NSC 76851; NSC-76851; NSC76851; Fluonid; Loflucarbanum; Fluonilide;

IUPAC/Chemical Name

1-(3,5-dichlorophenyl)-3-(4-fluorophenyl)thiourea

InChi Key

ZHNUMLOCJMCLIT-UHFFFAOYSA-N

InChi Code

InChI=1S/C13H9Cl2FN2S/c14-8-5-9(15)7-12(6-8)18-13(19)17-11-3-1-10(16)2-4-11/h1-7H,(H2,17,18,19)

SMILES Code

S=C(NC1=CC=C(F)C=C1)NC2=CC(Cl)=CC(Cl)=C2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 315.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Thuan NK, Naher K, Kubo R, Taniguchi T, Hayashidani H. Evaluation of Chromogenic Medium for Selective Isolation of Yersinia. Shokuhin Eiseigaku Zasshi. 2016;57(5):166-168. PubMed PMID: 27784868. 2: Nishi K, Suzuki K, Sawamoto J, Tokizawa Y, Iwase Y, Yumita N, Ikeda T. Inhibition of Fatty Acid Synthesis Induces Apoptosis of Human Pancreatic Cancer Cells. Anticancer Res. 2016 Sep;36(9):4655-60. PubMed PMID: 27630308. 3: Riber L, Burmølle M, Alm M, Milani SM, Thomsen P, Hansen LH, Sørensen SJ. Enhanced plasmid loss in bacterial populations exposed to the antimicrobial compound irgasan delivered from interpenetrating polymer network silicone hydrogels. Plasmid. 2016 Sep - Nov;87-88:72-78. doi: 10.1016/j.plasmid.2016.10.001. Epub 2016 Oct 12. PubMed PMID: 27743797. 4: G Archana, Dhodapkar R, Kumar A. Offline solid-phase extraction for preconcentration of pharmaceuticals and personal care products in environmental water and their simultaneous determination using the reversed phase high-performance liquid chromatography method. Environ Monit Assess. 2016 Sep;188(9):512. doi: 10.1007/s10661-016-5510-1. Epub 2016 Aug 9. PubMed PMID: 27502523. 5: Tan LK, Ooi PT, Carniel E, Thong KL. Evaluation of a modified Cefsulodin-Irgasan-Novobiocin agar for isolation of Yersinia spp. PLoS One. 2014 Aug 29;9(8):e106329. doi: 10.1371/journal.pone.0106329. eCollection 2014. PubMed PMID: 25170941; PubMed Central PMCID: PMC4149559. 6: Condie LW, Buhler DR. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat. Biochem Pharmacol. 1979;28(3):375-80. PubMed PMID: 426854. 7: Rüttermann S, Trellenkamp T, Bergmann N, Beikler T, Ritter H, Janda R. Bacterial viability and physical properties of antibacterially modified experimental dental resin composites. PLoS One. 2013 Nov 1;8(11):e79119. doi: 10.1371/journal.pone.0079119. eCollection 2013. Erratum in: PLoS One. 2015;10(5):e0126198. PubMed PMID: 24223890; PubMed Central PMCID: PMC3815119. 8: González M, Gude MJ, Seral C, Abad MP, Algarate S, Castillo FJ. [Comparasion of two methods for recovery of Aeromonas spp. in feces from agar CIN (Cefsulodin-Irgasan-Novobiocin)]. Rev Esp Quimioter. 2010 Dec;23(4):217-8. Spanish. PubMed PMID: 21191564. 9: Kanetoshi A, Ogawa H, Katsura E, Okui T, Kaneshima H. Disposition and excretion of Irgasan DP300 and its chlorinated derivatives in mice. Arch Environ Contam Toxicol. 1988 Sep;17(5):637-44. PubMed PMID: 3214192. 10: Pyle JA, Warwick NJ, Harris NR, Abas MR, Archibald AT, Ashfold MJ, Ashworth K, Barkley MP, Carver GD, Chance K, Dorsey JR, Fowler D, Gonzi S, Gostlow B, Hewitt CN, Kurosu TP, Lee JD, Langford SB, Mills G, Moller S, MacKenzie AR, Manning AJ, Misztal P, Nadzir MS, Nemitz E, Newton HM, O'Brien LM, Ong S, Oram D, Palmer PI, Peng LK, Phang SM, Pike R, Pugh TA, Rahman NA, Robinson AD, Sentian J, Samah AA, Skiba U, Ung HE, Yong SE, Young PJ. The impact of local surface changes in Borneo on atmospheric composition at wider spatial scales: coastal processes, land-use change and air quality. Philos Trans R Soc Lond B Biol Sci. 2011 Nov 27;366(1582):3210-24. doi: 10.1098/rstb.2011.0060. PubMed PMID: 22006963; PubMed Central PMCID: PMC3179638. 11: Fonseca K, MacDougall J, Pitt TL. Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media. J Clin Pathol. 1986 Feb;39(2):220-2. PubMed PMID: 3081597; PubMed Central PMCID: PMC499682. 12: Rudzok S, Schlink U, Herbarth O, Bauer M. Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2. Toxicol Appl Pharmacol. 2010 May 1;244(3):336-43. doi: 10.1016/j.taap.2010.01.012. Epub 2010 Feb 2. PubMed PMID: 20132835. 13: Meincke BE, Kranz RG, Lynch DL. Effect of irgasan on bacterial growth and its adsorption into the cell wall. Microbios. 1980;28(113-114):133-47. PubMed PMID: 6787394. 14: Hilbert F, Mayrhofer S, Smulders FJ. Rapid urease screening of Yersinia on CIN agar plates. Int J Food Microbiol. 2003 Jul 15;84(1):111-5. PubMed PMID: 12781961. 15: Kingston D, Hill ID. Elution of disinfectant from polyurethane cannula tubing. J Hosp Infect. 1990 Oct;16(3):271-80. PubMed PMID: 1979578. 16: Altwegg M, Zollinger-Iten J, von Graevenitz A. Differentiation of Kluyvera cryocrescens from Kluyvera ascorbata by irgasan susceptibility testing. Ann Inst Pasteur Microbiol (1985). 1986 Mar-Apr;137A(2):159-68. PubMed PMID: 3426156. 17: Martin EB, Mansfield LP, Smith A, Forsythe SJ. Inhibition of light emission from the bioluminescent bacterium Vibrio fischeri after exposure to triclosan and related hygiene care products. Luminescence. 2001 Jan-Feb;16(1):29-32. PubMed PMID: 11180655. 18: De Zutter L, Le Mort L, Janssens M, Wauters G. Short-comings of irgasan ticarcillin chlorate broth for the enrichment of Yersinia enterocolitica biotype 2, serotype 9 from meat. Int J Food Microbiol. 1994 Oct;23(2):231-7. PubMed PMID: 7848786. 19: Kingston D, Birnie ED, Martin J, Pearce PC, Manek S, Quinn CM. Experimental pathology of intravenous polyurethane cannulae containing disinfectant. J Hosp Infect. 1992 Apr;20(4):257-70. PubMed PMID: 1350602. 20: Devenish JA, Schiemann DA. An abbreviated scheme for identification of Yersinia enterocolitica isolated from food enrichments on CIN (cefsulodin-irgasan-novobiocin) agar. Can J Microbiol. 1981 Sep;27(9):937-41. PubMed PMID: 7306881.